Novorex
Seongnam
About Novorex
Novorex specializes in the development of molecule drugs targeting oncology and neurology diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2023)
- Website: novorex.com
- Phone: +82 031 8039 7281
Industries & Categories
Medical, Neuroscience, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/novorex-10896 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.